Floatz logo

Gm-Csf

Aplastic Anemia

Beth Israel Deaconess Medical CenterPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

16 Active assets in the Aplastic Anemia cohort.

Asset / SponsorPhaseRating
Fludarabine
Thomas Jefferson University
Phase 2BBB
Cyclophosphamide
Thomas Jefferson University
Phase 3BBB
TACROLIMUS
Thomas Jefferson University
Phase 2BB
FILGRASTIM
Thomas Jefferson University
Phase 2BB
Monomethyl Fumarate
Thomas Jefferson University
Phase 2BB

View all 36 →

Same molecule, other indications

Gm-Csf is also rated in:

melanomaDormant
BBB
Indicative ·
74 / 100
View asset →
acute lymphoblastic leukemiaDormant
BBB
Indicative ·
74 / 100
View asset →
uveal melanomaDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →